Barclays PLC Boosts Stake in Structure Therapeutics Inc. (NASDAQ:GPCR)
Barclays PLC lifted its position in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 42.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 115,671 shares of the company’s stock after purchasing an additional 34,533 shares during the quarter. Barclays PLC’s […]
Barclays PLC lifted its position in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 42.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 115,671 shares of the company’s stock after purchasing an additional 34,533 shares during the quarter. Barclays PLC’s […]
